The major histocompatibility complex (MHC, the HLA system in humans) is the antigen-presentation machinery of adaptive immunity: cell-surface glycoproteins that bind peptide fragments intracellularly and display them at the surface for inspection by T-cell receptors. Class I molecules (HLA-A, -B, -C) show endogenous peptides to CD8 T cells on nearly every cell; class II molecules (HLA-DR, -DP, -DQ) show endocytosed peptides to CD4 cells on professional antigen-presenting cells. The system's staggering polymorphism — the most variable loci in the human genome — balances pathogen coverage against autoimmunity and dictates transplantation compatibility.
Gene
HLA-A/B/C (class I); HLA-DR/DQ/DP (class II) on chromosome 6p21
Family
Immunoglobulin superfamily (MHC fold)
Location
All nucleated cells (I); APCs — dendritic, B, macrophage (II)
Structure
Class I: heavy chain + β2-microglobulin; class II: α/β heterodimer
Binding Partners
Peptides (8–10 aa class I, 13–17 aa II), TCR, CD8/CD4 co-receptors
Structure
The MHC fold cradles a peptide in a groove of two α-helices over a β-sheet floor — class I closed at both ends (8–10-mers), class II open (longer peptides).
Polymorphism concentrates in the groove's pocket-lining residues — each allele a different peptide-binding preference, thousands of alleles per locus in human populations.
The co-receptors lock the interaction: CD8 on class I, CD4 on class II — the anatomical basis of cytotoxic-versus-helper T-cell lineages.
Function
Surveillance: the proteasome's peptides, ferried by TAP into the ER, load class I — a virus-infected or tumor-mutated cell files its own report to CD8 killers, proteasome and TAP the machinery (see Ig-superfamily receptors reading it).
Instruction: dendritic cells' class II (loaded in endosomes/lysosomes) primes CD4 helpers — the step vaccines aim at; cross-presentation bridges the two worlds.
Self-education: thymic positive and negative selection on self-peptide-MHC shapes the T-cell repertoire — tolerance and MHC restriction learned together in the thymus — see immune system.
Regulation
Interferons and TNF up-regulate both classes (the immunoproteasome reshapes class I's peptide supply); some viruses (CMV, HIV) down-regulate MHC to hide infected cells.
Class II's invariant chain (CLIP) blocks the groove until edited by HLA-DM — quality control of peptide cargo.
Tapasin and the peptide-loading complex chaperone class I — each step a named component of antigen-processing biology.
Interactions
With immunoglobulin-superfamily TCRs: the immunological synapse — TCR on MHC-peptide, co-receptor, costimulation (CD28-B7) required for activation.
With NK cells' inhibitory receptors: "missing self" — cells that shed MHC I are killed by NK; the two systems close each other's loophole.
With regulatory T cells: recognition of self-peptide-MHC keeps tolerance active, not just developmental.
Clinical Relevance
Transplantation: HLA matching plus crossmatching is kidney and hematopoietic grafting's prerequisite; HLA antibodies mediate rejection.
Autoimmunity: HLA associations define disease risk — HLA-B27 (ankylosing spondylitis), HLA-DQ2/DQ8 (celiac), HLA-DR4 (rheumatoid, type 1 diabetes) — the strongest genetic signals in medicine.
Drug hypersensitivity and pharmacogenomics: HLA-B*57:01 (abacavir), B*15:02 (carbamazepine) — pre-prescription genotyping now standard; HLA typing of transplant panels also builds population-history anthropology.